See All Slides - tctmd.com

Slides

Presentation TCT 2015

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Neal S. Kleiman

October 11, 2015

Presentation TCT 2015

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Presenter: Thomas Engstroem, Barry D. Rutherford, Shamir R. Mehta

October 11, 2015

Presentation TCT 2015

Design of Current-Generation Durable-Polymer Drug-Eluting Stents: More Alike or Different?

Presenter: Stephen G. Ellis, John A. Ormiston

October 11, 2015

Presentation TCT 2015

Below-the-Knee Disease: Salvaging the Limb

Presenter: Julie Logan, Craig M. Walker

October 11, 2015

Presentation TCT 2015

Role of Atherectomy in Lower-Extremity Disease

Presenter: Julie Logan, Roger Gammon

October 11, 2015

Presentation TCT 2015

Atherotomy, Atherectomy, and Embolic Protection

Presenter: Robert T. Pyo, Bonnie H. Weiner, Davide Capodanno

October 11, 2015

Presentation TCT 2015

Do We Need to Reevaluate Our PTA Technique? Lessons Learned From Drug-Eluting Balloons

Presenter: Julie Logan, Krishna J. Rocha-Singh

October 11, 2015

Presentation TCT 2015

Pharmacology in the Lab: Heparin or Bivalirudin?

Presenter: Robert J. Applegate, Ehtisham Mahmud

October 11, 2015

Presentation TCT 2015

NSTE-ACS Case Presentation: From Presentation Through Discharge

Presenter: Ajay J. Kirtane, Gary S. Mintz, Manish A. Parikh, Bo Xu, Qi Zhang

October 11, 2015

Presentation TCT 2015

Debate: For SFA Disease I Prefer a Drug-Coated Balloon With Provisional Bare-Metal Stenting

Presenter: Julie Logan, George L Adams

October 11, 2015

Advertisement

Slides

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Design of Current-Generation Durable-Polymer Drug-Eluting Stents: More Alike or Different?

Below-the-Knee Disease: Salvaging the Limb

Role of Atherectomy in Lower-Extremity Disease

Atherotomy, Atherectomy, and Embolic Protection

Do We Need to Reevaluate Our PTA Technique? Lessons Learned From Drug-Eluting Balloons

Pharmacology in the Lab: Heparin or Bivalirudin?

NSTE-ACS Case Presentation: From Presentation Through Discharge

Debate: For SFA Disease I Prefer a Drug-Coated Balloon With Provisional Bare-Metal Stenting

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content